These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 12297762

  • 1. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.
    Andriulli A, Clemente R, Solmi L, Terruzzi V, Suriani R, Sigillito A, Leandro G, Leo P, De Maio G, Perri F.
    Gastrointest Endosc; 2002 Oct; 56(4):488-95. PubMed ID: 12297762
    [Abstract] [Full Text] [Related]

  • 2. Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.
    Andriulli A, Solmi L, Loperfido S, Leo P, Festa V, Belmonte A, Spirito F, Silla M, Forte G, Terruzzi V, Marenco G, Ciliberto E, Sabatino A, Monica F, Magnolia MR, Perri F.
    Clin Gastroenterol Hepatol; 2004 Aug; 2(8):713-8. PubMed ID: 15290665
    [Abstract] [Full Text] [Related]

  • 3. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis.
    Andriulli A, Leandro G, Federici T, Ippolito A, Forlano R, Iacobellis A, Annese V.
    Gastrointest Endosc; 2007 Apr; 65(4):624-32. PubMed ID: 17383459
    [Abstract] [Full Text] [Related]

  • 4. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.
    Andriulli A, Leandro G, Niro G, Mangia A, Festa V, Gambassi G, Villani MR, Facciorusso D, Conoscitore P, Spirito F, De Maio G.
    Gastrointest Endosc; 2000 Jan; 51(1):1-7. PubMed ID: 10625786
    [Abstract] [Full Text] [Related]

  • 5. Somatostatin and gabexate for post-endoscopic retrograde cholangiopancreatography pancreatitis prevention: meta-analysis of randomized placebo-controlled trials.
    Rudin D, Kiss A, Wetz RV, Sottile VM.
    J Gastroenterol Hepatol; 2007 Jul; 22(7):977-83. PubMed ID: 17559376
    [Abstract] [Full Text] [Related]

  • 6. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
    Cavallini G, Tittobello A, Frulloni L, Masci E, Mariana A, Di Francesco V.
    N Engl J Med; 1996 Sep 26; 335(13):919-23. PubMed ID: 8786777
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
    Manes G, Ardizzone S, Lombardi G, Uomo G, Pieramico O, Porro GB.
    Gastrointest Endosc; 2007 Jun 26; 65(7):982-7. PubMed ID: 17531632
    [Abstract] [Full Text] [Related]

  • 8. Antiproteases in preventing post-ERCP acute pancreatitis.
    Tsujino T, Kawabe T, Omata M.
    JOP; 2007 Jul 09; 8(4 Suppl):509-17. PubMed ID: 17625308
    [Abstract] [Full Text] [Related]

  • 9. Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Xiong GS, Wu SM, Zhang XW, Ge ZZ.
    Braz J Med Biol Res; 2006 Jan 09; 39(1):85-90. PubMed ID: 16400468
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial.
    Ueki T, Otani K, Kawamoto K, Shimizu A, Fujimura N, Sakaguchi S, Matsui T.
    J Gastroenterol; 2007 Feb 09; 42(2):161-7. PubMed ID: 17351806
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Could nafamostat or gabexate prevent the post endoscopic retrograde cholangiopancreatography pancreatitis?].
    Kwon YH, Kim JY, Lee SJ, Jang SY, Park HW, Yang HM, Jung MK, Jeon SW, Cho CM, Tak WY, Kweon YO, Kim SK.
    Korean J Gastroenterol; 2012 Mar 09; 59(3):232-8. PubMed ID: 22460572
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevention of post-ERCP pancreatitis.
    Haber GB.
    Gastrointest Endosc; 2000 Jan 09; 51(1):100-3. PubMed ID: 10625814
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of two dosing regimens of gabexate in the prophylaxis of post-ERCP pancreatitis.
    Masci E, Cavallini G, Mariani A, Frulloni L, Testoni PA, Curioni S, Tittobello A, Uomo G, Costamagna G, Zambelli S, Macarri G, Innocenti P, Dragonetti C, Gabexate in Digestive Endoscopy-Italian Group II.
    Am J Gastroenterol; 2003 Oct 09; 98(10):2182-6. PubMed ID: 14572565
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.